> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Extension for Biologic Cooperative Manufacturing
- URL: https://www.fdaweb.com/info-collection-extension-for-biologic-cooperative-manufacturing/
- Published: 2018-01-09T12:00:00.000Z
- Updated: 2026-09-14T23:12:03.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140449

*Federal Register* notice: FDA has submitted to OMB for clearance an information collection extension for “Cooperative Manufacturing Arrangements for Licensed Biologics OMB Control Number 0910-0629.” The information collection supports the agency’s “Guidance for Industry: [Cooperative Manufacturing for Licensed Biologics](https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/General/ucm069908.pdf?ref=fdaweb.com), which addresses several types of manufacturing arrangements (i.e., short supply arrangements, divided manufacturing arrangements, shared manufacturing arrangements, and contract manufacturing arrangements) and describes certain reporting and recordkeeping responsibilities associated with these arrangements. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-00238.pdf?ref=fdaweb.com).